MENU
+Compare
MIST
Stock ticker: NASDAQ
AS OF
Sep 15, 04:48 PM (EDT)
Price
$1.97
Change
+$0.01 (+0.51%)
Capitalization
166.59M

MIST Milestone Pharmaceuticals Forecast, Technical & Fundamental Analysis

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines... Show more

MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MIST with price predictions
Sep 12, 2025

MIST sees its Stochastic Oscillator climbs out of oversold territory

On September 11, 2025, the Stochastic Oscillator for MIST moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 11, 2025. You may want to consider a long position or call options on MIST as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MIST just turned positive on September 11, 2025. Looking at past instances where MIST's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

MIST moved above its 50-day moving average on August 27, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MIST crossed bullishly above the 50-day moving average on August 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MIST advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 143 cases where MIST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MIST broke above its upper Bollinger Band on September 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.960) is normal, around the industry mean (20.731). P/E Ratio (0.000) is within average values for comparable stocks, (53.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.171). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (74.074) is also within normal values, averaging (337.655).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MIST is expected to report earnings to fall 21.25% to -15 cents per share on November 12

Milestone Pharmaceuticals MIST Stock Earnings Reports
Q3'25
Est.
$-0.16
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.11
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
The last earnings report on August 12 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 763.47K shares outstanding, the current market capitalization sits at 166.59M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FHELF0.02N/A
+20.56%
FIRST HELIUM INC
NPACY1.460.06
+4.20%
Quadient SA
ESHDF0.32N/A
N/A
Esprit Holdings Ltd.
JFROF11.10N/A
N/A
J. Front Retailing Co., Ltd.
DSFIY9.51-0.02
-0.21%
DSM Firmenich AG

MIST and Stocks

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+2.62%
AKBA - MIST
33%
Poorly correlated
-1.34%
ETNB - MIST
30%
Poorly correlated
-6.71%
GYRE - MIST
29%
Poorly correlated
-3.57%
PRAX - MIST
29%
Poorly correlated
-4.35%
OSRH - MIST
29%
Poorly correlated
+1.66%
More